These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9568286)

  • 41. Synthesis and biological activity of novel 1,3-benzoxazine derivatives as K+ channel openers.
    Yamamoto S; Hashiguchi S; Miki S; Igata Y; Watanabe T; Shiraishi M
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):734-45. PubMed ID: 8681405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 4,6-Disubstituted 2,2-dimethylchromans structurally related to the K(ATP) channel opener cromakalim: design, synthesis, and effect on insulin release and vascular tone.
    Sebille S; de Tullio P; Becker B; Antoine MH; Boverie S; Pirotte B; Lebrun P
    J Med Chem; 2005 Jan; 48(2):614-21. PubMed ID: 15658874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tedisamil (KC 8857) differentially inhibits the 86Rb+ efflux-stimulating and vasorelaxant properties of cromakalim.
    Bray K; Quast U
    Eur J Pharmacol; 1991 Jul; 200(1):163-5. PubMed ID: 1769368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potassium channel openers relax A23187-induced nifedipine-resistant contraction of rat aorta.
    Yamashita T; Masuda Y; Tanaka S
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):914-20. PubMed ID: 7898074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The synthesis and biological evaluation of a range of novel functionalized benzopyrans as potential potassium channel activators.
    Tyrrell E; Tesfa KH; Greenwood I; Mann A
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1237-40. PubMed ID: 18191566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temperature-sensitive effects of potassium channel openers on isolated guinea pig myocardium and aorta.
    Saito W; Noguchi K; Okazaki K; Matsuda T; Kato Y; Tanaka H; Shigenobu K
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):327-9. PubMed ID: 9475277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potassium channel activators based on the benzopyran substructure: synthesis and activity of the C-8 substituent.
    Thompson R; Doggrell S; Hoberg JO
    Bioorg Med Chem; 2003 Apr; 11(8):1663-8. PubMed ID: 12659752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasorelaxant effects of methyl brevifolincarboxylate from the leaves of Phyllanthus niruri.
    Iizuka T; Moriyama H; Nagai M
    Biol Pharm Bull; 2006 Jan; 29(1):177-9. PubMed ID: 16394535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues.
    Horino H; Mimura T; Kagechika K; Ohta M; Kubo H; Kitagawa M
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):602-9. PubMed ID: 9579035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of and radioligand binding studies with a tritiated pinacidil analogue: receptor interactions of structurally different classes of potassium channel openers and blockers.
    Manley PW; Quast U; Andres H; Bray K
    J Med Chem; 1993 Jul; 36(14):2004-10. PubMed ID: 8336339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships.
    de Tullio P; Pirotte B; Lebrun P; Fontaine J; Dupont L; Antoine MH; Ouedraogo R; Khelili S; Maggetto C; Masereel B; Diouf O; Podona T; Delarge J
    J Med Chem; 1996 Feb; 39(4):937-48. PubMed ID: 8632417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relaxation of human coronary artery and arteria mammaria by K(+)-channel openers.
    Bossaller C; Auch-Schwelk W; Graf K; Gräfe M; Catadelgirmen G; Ennker J; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S13-6. PubMed ID: 1282170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta.
    Kashiwabara T; Nakajima S; Izawa T; Fukushima H; Nishikori K
    Eur J Pharmacol; 1991 Apr; 196(1):1-7. PubMed ID: 1678711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1,4-Benzothiazine ATP-sensitive potassium channel openers: modifications at the C-2 and C-6 positions.
    Martelli A; Manfroni G; Sabbatini P; Barreca ML; Testai L; Novelli M; Sabatini S; Massari S; Tabarrini O; Masiello P; Calderone V; Cecchetti V
    J Med Chem; 2013 Jun; 56(11):4718-28. PubMed ID: 23662847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 6-Sulfonylchromenes as highly potent K(ATP)-channel openers.
    Salamon E; Mannhold R; Weber H; Lemoine H; Frank W
    J Med Chem; 2002 Feb; 45(5):1086-97. PubMed ID: 11855989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of guinea-pig tracheal smooth muscle responsiveness by the potassium channel openers NIP-121 and cromakalim.
    Shikada K; Yamamoto A; Tanaka S
    Jpn J Pharmacol; 1992; 58 Suppl 2():334P. PubMed ID: 1507583
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of potassium channel openers on hypoxic pulmonary vasoconstriction].
    Matsumoto H; Nakano H; Akiba Y; Osanai S; Tobise K; Onodera S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1488-95. PubMed ID: 1434222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Halothane attenuates endothelium-dependent pulmonary vasorelaxant response to lemakalim, an adenosine triphosphate (ATP)-sensitive potassium channel agonist.
    Seki S; Horibe M; Murray PA
    Anesthesiology; 1997 Sep; 87(3):625-34. PubMed ID: 9316969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.